Track market-moving stories before they get noisy

, /PRNewswire/ -- Burford Capital Limited ("Burford"), the leading global finance and asset management firm focused on law, today provides an update on a portfolio matter.

After the market close on Friday, September 25, 2026, a jury in a case in which Burford has a financial entitlement awarded $5.7 billion in damages to the plaintiff. That amount is likely to be altered in post-trial and/or appellate proceedings, but if the verdict amount were paid, as is, Burford's entitlement would be $1.4 billion, split roughly equally between Burford's balance sheet and its investment funds.

Burford has elected to issue this release given media coverage of this matter that has already occurred. Investors should not view this release as altering Burford's general approach to public disclosure of individual matters.

It has been publicly reported that the verdict, in a case captioned Taction Technology, Inc. v. Apple Inc., represents one of the largest patent verdicts in U.S. history. It is important to view the verdict through the lens of the patent litigation process. This includes post-trial proceedings that have yet to occur (including a motion by Apple for judgment as a matter of law—in other words, asking the trial court to set aside the jury's verdict) and significant appellate scrutiny of large verdicts by the U.S. Court of Appeals for the Federal Circuit. Indeed, very few large patent verdicts survive the post-verdict process intact, and that process will unfold over a considerable period of time.

The issuance of the jury verdict does not represent a final judgment or cash proceeds received by Burford. The case remains subject to significant litigation and collection risks, including potential post-trial and appellate proceedings, as well as enforcement, collection and collateral litigation in other jurisdictions. As with all litigation, the outcome remains uncertain until final resolution, and there can be no assurance as to the timing or amount of any ultimate recovery. Depending on the outcome of such proceedings, Burford could recover substantially less than the amount set forth above or, in certain circumstances, incur a total loss. Litigation matters also frequently resolve for amounts materially below the amount of a verdict or judgment, and the parties could agree to resolve this matter for considerably less than the amount of the verdict. Burford's ultimate entitlement, if any, will also depend on the terms of its financing agreement and applicable fees, expenses, taxes and other deductions. In addition, if settlement or other resolution discussions occur, Burford may be unable to comment publicly on those discussions until their conclusion. Burford disclaims, to the fullest extent permitted by law, any obligation to update its statements regarding this matter as the proceedings continue.

About Burford Capital

Burford Capital is the leading global finance and asset management firm focused on law. Its businesses include litigation finance and risk management, asset recovery and a wide range of legal finance and advisory activities. Burford is publicly traded on the New York Stock Exchange (NYSE: BUR) and the London Stock Exchange (LSE: BUR) and works with companies and law firms around the world from its global network of offices.

For more information, please visit www.burfordcapital.com.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any ordinary shares or other securities of Burford.

This press release does not constitute an offer of any Burford private fund. Burford Capital Investment Management LLC, which acts as the fund manager of all Burford private funds, is registered as an investment adviser with the US Securities and Exchange Commission. The information provided in this press release is for informational purposes only. Past performance is not indicative of future results. The information contained in this press release is not, and should not be construed as, an offer to sell or the solicitation of an offer to buy any securities (including interests or shares in any of Burford private funds). Any such offer or solicitation may be made only by means of a final confidential private placement memorandum and other offering documents.

Forward-looking statements

This press release contains "forward-looking statements" within the meaning of Section 27A of the US Securities Act of 1933, as amended, and Section 21E of the US Securities Exchange Act of 1934, as amended, that are intended to be covered by the safe harbor provided for under these sections. In some cases, words such as "aim", "anticipate", "believe", "continue", "could", "estimate", "expect", "forecast", "guidance", "intend", "may", "plan", "potential", "predict", "projected", "should" or "will", or the negative of such terms or other comparable terminology, are intended to identify forward-looking statements. Although Burford believes that the assumptions, expectations, projections, intentions and beliefs about future results and events reflected in forward-looking statements have a reasonable basis and are expressed in good faith, forward-looking statements involve known and unknown risks, uncertainties and other factors, which could cause Burford's actual results and events to differ materially from (and be more negative than) future results and events expressed, projected or implied by these forward-looking statements. Factors that might cause future results and events to differ include, among others, those discussed in the "Risk Factors" section of Burford's Annual Report on Form 10-K for the year ended December 31, 2025 filed with the US Securities and Exchange Commission on February 26, 2026 and in Burford's subsequent Quarterly Reports on Form 10-Q. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements contained in the periodic and current reports that Burford files with or furnishes to the US Securities and Exchange Commission. Many of these factors are beyond Burford's ability to control or predict, and new factors emerge from time to time. Furthermore, Burford cannot assess the impact of each such factor on its business or the extent to which any factor or combination of factors may cause actual results and events to be materially different from those contained in any forward-looking statement. Given these uncertainties, readers are cautioned not to place undue reliance on Burford's forward-looking statements.

All subsequent written and oral forward-looking statements attributable to Burford or to persons acting on its behalf are expressly qualified in their entirety by these cautionary statements. The forward-looking statements speak only as of the date of this press release and, except as required by applicable law, Burford undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

View original content:https://www.prnewswire.com/news-releases/statement-regarding-jury-verdict-in-patent-matter-302890959.html

SOURCE Burford Capital Limited

Shares of Burford Capital Limited (LON:BUR – Get Free Report) passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 379.43 and traded as low as GBX 319.60. Burford Capital shares last traded at GBX 319.60, with a volume of 182,136 shares.

Analyst Ratings Changes Separately, Berenberg Bank reaffirmed a “buy” rating and set a GBX 450 price objective on shares of Burford Capital in a research report on Friday, August 7th. One equities research analyst has rated the stock with a Buy rating, According to data from MarketBeat.com, the company currently has an average rating of “Buy” and an average target price of GBX 450.

Read Our Latest Report on Burford Capital

Burford Capital Price Performance The company has a market capitalization of £724.63 million, a PE ratio of -0.43, a price-to-earnings-growth ratio of 1.09 and a beta of 1.06. The company has a debt-to-equity ratio of 294.89, a current ratio of 3.20 and a quick ratio of 8.01. The stock’s 50 day simple moving average is GBX 315.83 and its 200-day simple moving average is GBX 379.43. (Get Free Report)

Burford Capital is the leading global finance and asset management firm focused on law. Its businesses include litigation finance and risk management, asset recovery and a wide range of legal finance and advisory activities. Burford is publicly traded on the New York Stock Exchange (NYSE: BUR) and the London Stock Exchange (LSE: BUR) and works with companies and law firms around the world from its global network of offices.

Featured Stories Five stocks we like better than Burford Capital Qualcomm’s Data Center Bet Looks More Real After Amazon’s AI Deal GE Aerospace’s $11.75B Deal Puts Howmet Aerospace in Focus Casey’s Post-Earnings Drop May Give Investors a Better Entry Into a Quality Retailer Sovereign AI: Palantir and Nebius Cut the Cloud Cord Receive News & Ratings for Burford Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Burford Capital and related companies with MarketBeat.com's FREE daily email newsletter.

Burford Capital Statement Re Cameroon Mining Arbitration Matter PR Newswire NEW YORK, July 24, 2026

A rollercoaster quarter for AIM, over which the index lost 5%, ended with a flourish, with the small-cap benchmark up 1.4% over the last five trading days as a little confidence was restored to the market.

That said, it underperformed the FTSE 100, which advanced almost 4% over the trading week, pricing in a potential return to normality if Donald Trump follows through with his rhetoric to end the Iran conflict in a matter of weeks.

Up 45% over the week, RC Fornax PLC (AIM:RCFX), the veteran-led defence consultancy, was boosted by a positive trading update on Tuesday in which it reported £1.4 million of new orders and purchase order extensions during March. That lifted its revenue visibility for the current financial year to more than £5.1 million.

Cavendish, the company's corporate broker, maintained its 'buy' rating and 50p target price on the stock. That's a bullish call, given the shares are currently changing hands at 10.5p.

Everyman gets a director vote of confidence

Everyman Media Group PLC (AIM:EMAN), the upmarket cinema chain where you can have an Italian bottled beer and charcuterie board delivered to your seat, was near the top of the bill after a 35% jump in its share price.

It followed share purchases by director and ASK Pizza founder Samuel Kaye, which has taken his stake in the business to 8.36%.

Not far behind with a 33% advance was Silver Bullet Data Services Group PLC (AIM:SBDS) where investor Keith Morris has doubled his stake up to almost 18%.

BRCK Group shares surged 30% after the brick distributor said it had rejected a takeover approach from US private equity firm Atlas Holdings, saying the indicative 65p per share cash offer fundamentally undervalued the business. It remains to be seen whether Atlas will make a second pass for a company whose stock has halved in value since its September 2021 high.

Catenai PLC (AIM:CTEA) rose 22% to 0.3p after Alludium, its investee company and developer of a no-code artificial intelligence agent operating system, achieved two internationally recognised information security certifications.

Up 10%, rapid diagnostic tests specialist Abingdon Health PLC (AIM:ABDX) was buoyed by the award of a series of significant contracts with a US customer to develop and scale up the manufacture of several multiplex quantitative lateral flow assay systems measuring multiple biomarkers simultaneously in human samples.

Mirriad runs out of road

Onto the week's big losers. Leading the list was Mirriad Advertising PLC (AIM:MIRI, FRA:8WQ, OTCQX:MMDDF), which specialises in the rather niche area of inserting advertising into film, TV and sports content. One suspects it's an area that AI will trounce without even a sideways glance.

Anyway, this week's news was less about competition and very much about the financial here and now of the business, which is running short of cash. That set off alarm bells as the stock fell 52%. The damage would have been worse if not for a revival of sorts in the share price on Friday.

Shares in Burford Capital Limited (LSE:BUR), which finances legal cases, dropped 46% to a six-year low after a US federal appeals court overturned a $16.1 billion judgment against Argentina in the long-running YPF nationalisation case. Analysts at Berenberg had estimated the claim was worth around $3 billion to Burford. Argentina's president Javier Milei celebrated the 2-1 Manhattan court ruling on X.

Litigation Capital Management Ltd (AIM:LIT),  which wasn't involved in the case, was off 31% after what it described as a challenging financial first half. That's something of an understatement after booking a statutory loss of more than $100 million.

Down 22% over the week, the pain continued for Distil (AIM:DIS), the premium spirits group, after last week's warning that full-year revenues would miss market expectations by a material margin and that the business faces an immediate short-term funding need.

Under the radar: a biotech trust worth a look

And finally, International Biotechnology Trust (ISE:IBT) may be flying under the radar for investors looking for a diversified, income-generating route into one of the most dynamic corners of the market. The current discount of 12.5% to its net asset value would suggest so.

Managed by Ailsa Craig and Marek Poszepczynski at Schroders, the trust invests across around 100 quoted and unquoted biotech and life sciences companies, with a focus on oncology, rare diseases and mental health.

It has outperformed the Nasdaq Biotechnology Index with lower volatility over five years, and pays a dividend equivalent to 4% of net asset value annually.